Othonas Economopoulos

Othonas Economopoulos

Why Square Shares Are Trading Higher Today
Square (NYSE: SQ) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. Square was founded in 2009 and provides payment acquiring services to merchants, along with related services.
Why ChemoCentryx Shares Are Plunging Today
ChemoCentryx (NASDAQ: CCXI) shares are trading lower following a vote from the FDA panel on whether the efficacy data support approval on its Avacopan in ANCA-Associated vasculitis.
Why General Motors Shares Are Trading Higher Today
General Motors (NYSE: GM) shares are trading higher after the company reported better-than-expected EPS and sales results.
Why Is Spotify's Stock Trading Higher Today?
Spotify Technology (NYSE: SPOT) shares are trading higher after Pivotal Research upgraded the stock from Hold to Buy and announced a price target of $340 per share.
Why GameStop's Stock Is Trading Higher Today
GameStop (NYSE: GME) shares are trading higher after the company announced it completed its at-the-market equity offering.
Why ProofPoint's Stock Is Rallying Today
Proofpoint (NASDAQ: PFPT) shares are trading higher after the company reported better-than-expected EPS and sales results. The company also announced that Thoma Bravo wants to acquire the company for $176 per share in cash for a total of $12.3 billion.
EXUMA Biotech Is 'Revolutionizing CAR-T Therapy,' Increasing Patient Access, CEO Says
EXUMA Biotech is focused on developing a Chimeric Antigen Receptor (CAR)-T cell product for solid tumors. Chairman and CEO Dr. Greg Frost spoke with Benzinga about patient access to CAR-T therapies, the technology behind the company's two platforms for solid tumors and the impact the coronavirus pandemic has had on the company.  
RedHill's CEO On Biopharma's 'Two Shots On Goal' For Coronavirus Drug
REDHILL BIOPHAR/S ADR (NASDAQ: RDHL), known primarily as a biopharmaceutical company focused on gastrointestinal diseases, is joining the race to develop coronavirus treatments with two pipeline drugs it believes can help treat the disease that's triggered a pandemic. 
BioXcel Therapeutics CEO Says Wearable Devices Are Another Tool To Combat Alzheimer's Agitation
BioXcel Therapeutics (NASDAQ: BTAI) founder and CEO Dr.
Interpace Biosciences CEO Jack Stover On Diagnostics Business: 'Much Of The Growth Opportunity Is Around Awareness'
Why Inseego Products Are In Demand During The Pandemic
'Setting The Standard For Product Safety': Akerna's CEO Talks Cannabis Data
Pure Green CEO Discusses The Cannabis Company's Approach To Continued Growth
Neurotrope's Approach To Alzheimer's Disease: 'Our Improvement Data Is The Best Anyone Has'
Entasis Therapeutics CEO: 'Our Antibiotics Work Differently'
BioXcel's CEO On BXCL501: 'This Is A Pretty Unique Drug'
Biofrontera's CFO On The Dermatology Biotech's Pipeline, Growth, Acquisitions And More
BioXcel Pharmaceuticals CEO On Drug Pipeline, How AI Is Changing Sector
CIRCOR Shares Now Up 1.2% For Session
Tiziana Life Sciences Shares Resume Trade, Up 12% For Session

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved